Vascular endothelial growth factor

Vascular endothelial growth factor -634 G/C polymorphism and risk of cancer: an updated meta-analysis

J. Y. Ban, Shin, J. I., and Oh, C. - H., Vascular endothelial growth factor -634 G/C polymorphism and risk of cancer: an updated meta-analysis, vol. 14, pp. 13906-13914, 2015.

The association between vascular endothelial growth factor (VEGF) gene polymorphisms and risk of cancer has been investigated in several studies published previously; however, the individual results are inconclusive. Therefore, we performed a meta-analysis to establish evidence for an association between the VEGF -634 G/C polymorphism and risk of cancer. We searched PubMed, Medline, and Korean Studies Information Service System databases and identified 29 case-control studies, containing data of 25,324 individuals, for this meta-analysis.

Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis

Y. H. Lee and Song, G. G., Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis, vol. 14, pp. 14396-14405, 2015.

The aim of this study was to explore whether vascular endothelial growth factor (VEGF) polymorphisms confer susceptibil­ity to psoriasis. Meta-analyses were conducted to examine the asso­ciations between the +405 C/G, -460 C/T, -1154 A/G, and -2578 A/C polymorphisms of VEGF and psoriasis using allele contrast and reces­sive, dominant, and additive models. Seven studies on VEGF polymor­phisms and psoriasis involving 1956 subjects (psoriasis patients 665, controls 1291) were included in this meta-analysis.

Subscribe to Vascular endothelial growth factor